Insider trade

Director sold ~$3.27M of CORT shares in the open market

Traded Aug 26, 2026 · Filed Aug 29, 2026

Why it stands out

A board member of Corcept Therapeutics sold $3.27M of Corcept Therapeutics shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$3,270,169

Shares × reported transaction price

Timing vs results

28 days after results of Jul 29, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+0.6%	−0.1%	+0.7%
30 days	+1.7%	−0.6%	+2.2%

Past results only. Not a forecast.

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $122.50 to $122.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Scheduled in advance3w ago

3w ago

Derivative exercise or conversion — not an open-market buy.

3w ago

Derivative exercise or conversion — not an open-market buy.